During the past decade, San Juan Arthritis & Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "San Juan Arthritis & Research Center" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "San Juan Arthritis & Research Center" in a lesser frequency.

Most popular intervention types in "San Juan Arthritis & Research Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Humira (adalimumab)" (1 trials), "Placebo tofacitinib plus Methotrexate" (1 trials), "Tasocitinib plus Methotrexate" (1 trials) and "Tofacitinib plus placebo methotrexate" (1 trials). Other intervention names were less common.

The vast majority of trials in "San Juan Arthritis & Research Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "San Juan Arthritis & Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in San Juan Arthritis & Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in San Juan Arthritis & Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".